ITGB2 and neoplasm: IFNγ receptor signaling leads to an increase in the production of CXCR3 ligands, namely CXCL9, 10 and 11 which have the potential to promote the avidity of LFA-1 on T cells as well as to attract other immune effector cells to the tumor site.